Where do we go after GiACTA?

Rheumatology (Oxford). 2022 Jul 6;61(7):2720-2721. doi: 10.1093/rheumatology/keac010.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Giant Cell Arteritis*
  • Humans
  • Recurrence

Substances

  • Antibodies, Monoclonal, Humanized
  • tocilizumab